Market revenue in 2023 | USD 151.1 million |
Market revenue in 2030 | USD 403.4 million |
Growth rate | 15.1% (CAGR from 2023 to 2030) |
Largest segment | On-body |
Fastest growing segment | Off-body |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | On-body, Off-body |
Key market players worldwide | BD, Johnson & Johnson, Roche Holding AG, United Therapeutics Corp, Amgen Inc, Insulet Corp, West Pharmaceutical Services Inc, CeQur Simplicity, Unilife Corporation, Enable Injections |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to wearable injectors market will help companies and investors design strategic landscapes.
On-body was the largest segment with a revenue share of 52.02% in 2023. Horizon Databook has segmented the UAE wearable injectors market based on on-body, off-body covering the revenue growth of each sub-segment from 2018 to 2030.
The UAE government is loosening policies to attract foreign investments to expand and increase the healthcare standard and boost the healthcare industry. This represents a major opportunity for manufacturers operating in the market to expand their reach in the country.
Key factors driving the growth of the UAE wearable injectors market are increasing prevalence of chronic diseases and technological advancements in portable devices. At 16.3%, the UAE is among the countries with the highest diabetes prevalence in the world, according to 2019 IDF statistics.
The poll of more than 1,000 UAE residents indicated that the percentage of respondents directly affected with heart disease was 55%, either by their own diagnosis (12%), the diagnosis of a close friend or family member (53%), or both. In the UAE, cardiovascular disease is the main cause of mortality, with patients frequently experiencing symptoms a decade sooner than their counterparts in other industrialized nations.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE wearable injectors market , including forecasts for subscribers. This country databook contains high-level insights into UAE wearable injectors market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account